Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), TETRALITE clinical trials

A randomized first-in-human, Phase 1, single-center, observer-blind, active-controlled 3-arm study to evaluate the safety, tolerability, and immunogenicity of one single administration of TETRALITE, a novel adjuvanted influenza vaccine, in healthy participants aged 18 to 50 years

This study is testing a new flu vaccine called TETRALITE in healthy adults. Researchers want to see if it's safe, how well people tolerate it, and how strongly it helps the body fight off the flu compared to an existing flu vaccine.